Having trouble viewing this email? View it in your browser . View french version
We invite you to join our community of international oncologists and enjoy the very best and latest in precision medicine breast cancer news, editorial and educational programs. Register now
Featured program 

AI SERIES - A review of Precision medicine in cancer therapeutics - Hormone sensitive Breast Cancer and AI challenges. Pr. John Robertson presents the PROS and CONS of using ARTIFICIAL INTELLIGENCE in Precision Medicine for the treatment of Breast Cancer.

Watch now

OncoXchange editorial board
As internationally-recognized leaders in cancer research, our editorial board guides the platform with unparalleled expertise and insight.
Founding Editor
Kathleen Pritchard, MD 		Editor-in-Chief
Edith Perez, MD 		Scientific Editor
John Bartlett BSc, PhD

News and Editorial
AI SERIES
Panel Discussion: A review of Precision medicine in cancer therapeutics - Hormone sensitive Breast Cancer and AI challenges
September 20th 2021
Image ESMO 2021 - Immunotherapy but not PARP inhibitor improves outcomes when added to chemotherapy in early TNBC
September 21 2021
Image ESMO 2021 - Immunotherapy, CDK4/6 inhibition shown to improve survival in advanced breast cancer
October 4th 2021

Clinical Insights
AI SERIES presentation
Do we need Artificial Intelligence for Precision Medicine? Review of the structure of high dimensional omics, tissue and sample heterogeneity aspects, and AI-based tools for addressing dimensionality and heterogeneity.
Presentation by Pr. Robert Clarke Ph.D., D.Sc.
Insights from OICR
Characterization of immune "hot" hormone receptor positive breast cancer. A multi-omic approach to analyze (HR+ve) clinical cohort would help to identify groups of patients who can be managed with immune-therapy.
Presentation by Dr. Melanie Spears

Image As of now, the Group brings together ten hospitals, CIUSSS and CISSS located in several regions of Quebec that work together in one of the largest breast cancer clinical research consortiums in Canada
Dr. Louise Provencher, a newly retired surgical-oncologist at the CHU de Québec-Université Laval, brings her expertise to the benefit of the Group as Medical Advisor for the Accès-recherche Program
October 12, 2021
Dr. Jamil Asselah, Dr. Cristiano Ferrario, Dr. Sarkis Meterissian and Dr. Michel Pavic, all members of our Executive Scientific Committee (ESC), will participate in the Breast Health Forum of the Quebec Breast Cancer Foundation
Dr. Sarkis Meterissian, a surgical-oncologist and member of the ESC, will shave his head to raise funds for the Raise craze 2021 campaign and the wellness program of the Breast Clinic of the McGill University Health Center

To view more precision medicine breast cancer news, editorial and educational programs Register now

Visit us on the web at oncoxchange.org - Contact Us?
This newsletter is distributed by oncoXchange.org, the Precision Medicine Breast Cancer platform.
oncoXchange.org is owned and operated by MedcomXchange.
Head office: 1196, rue Sherbrooke Ouest, Montréal (QC) H3A 1R6 CANADA